Tags

Type your tag names separated by a space and hit enter

Fed-batch cultivation of Saccharomyces cerevisiae on lignocellulosic hydrolyzate.
Biotechnol Lett. 2007 Feb; 29(2):219-25.BL

Abstract

Saccharomyces cerevisiae grows very poorly in dilute acid lignocellulosic hydrolyzate during the anaerobic fermentation for fuel ethanol production. However, yeast cells grown aerobically on the hydrolyzate have increased tolerance for the hydrolyzate. Cultivation of yeast on part of the hydrolyzate has therefore the potential of enabling increased ethanol productivity in the fermentation of the hydrolyzate. To evaluate the ability of the yeast to grow in the hydrolyzate, fed-batch cultivations were run using the ethanol concentration as input variable to control the feed-rate. The yeast then grew in an undetoxified hydrolyzate with a specific growth rate of 0.19 h(-1) by controlling the ethanol concentration at a low level during the cultivation. However, the biomass yield was lower for the cultivation on hydrolyzate compared to synthetic media: with an ethanol set-point of 0.25 g/l the yield was 0.46 g/g on the hydrolyzate, compared to 0.52 g/g for synthetic media. The main reason for the difference was not the ethanol production per se, but a significant production of glycerol at a high specific growth rate. The glycerol production may be attributed to an insufficient respiratory capacity.

Authors+Show Affiliations

Department of Chemical Engineering, Lund University, Lund, Sweden.No affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

17091372

Citation

Petersson, Anneli, and Gunnar Lidén. "Fed-batch Cultivation of Saccharomyces Cerevisiae On Lignocellulosic Hydrolyzate." Biotechnology Letters, vol. 29, no. 2, 2007, pp. 219-25.
Petersson A, Lidén G. Fed-batch cultivation of Saccharomyces cerevisiae on lignocellulosic hydrolyzate. Biotechnol Lett. 2007;29(2):219-25.
Petersson, A., & Lidén, G. (2007). Fed-batch cultivation of Saccharomyces cerevisiae on lignocellulosic hydrolyzate. Biotechnology Letters, 29(2), 219-25.
Petersson A, Lidén G. Fed-batch Cultivation of Saccharomyces Cerevisiae On Lignocellulosic Hydrolyzate. Biotechnol Lett. 2007;29(2):219-25. PubMed PMID: 17091372.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Fed-batch cultivation of Saccharomyces cerevisiae on lignocellulosic hydrolyzate. AU - Petersson,Anneli, AU - Lidén,Gunnar, Y1 - 2006/11/08/ PY - 2006/08/30/received PY - 2006/09/27/accepted PY - 2006/11/9/pubmed PY - 2007/6/27/medline PY - 2006/11/9/entrez SP - 219 EP - 25 JF - Biotechnology letters JO - Biotechnol Lett VL - 29 IS - 2 N2 - Saccharomyces cerevisiae grows very poorly in dilute acid lignocellulosic hydrolyzate during the anaerobic fermentation for fuel ethanol production. However, yeast cells grown aerobically on the hydrolyzate have increased tolerance for the hydrolyzate. Cultivation of yeast on part of the hydrolyzate has therefore the potential of enabling increased ethanol productivity in the fermentation of the hydrolyzate. To evaluate the ability of the yeast to grow in the hydrolyzate, fed-batch cultivations were run using the ethanol concentration as input variable to control the feed-rate. The yeast then grew in an undetoxified hydrolyzate with a specific growth rate of 0.19 h(-1) by controlling the ethanol concentration at a low level during the cultivation. However, the biomass yield was lower for the cultivation on hydrolyzate compared to synthetic media: with an ethanol set-point of 0.25 g/l the yield was 0.46 g/g on the hydrolyzate, compared to 0.52 g/g for synthetic media. The main reason for the difference was not the ethanol production per se, but a significant production of glycerol at a high specific growth rate. The glycerol production may be attributed to an insufficient respiratory capacity. SN - 0141-5492 UR - https://www.unboundmedicine.com/medline/citation/17091372/Fed_batch_cultivation_of_Saccharomyces_cerevisiae_on_lignocellulosic_hydrolyzate_ L2 - https://doi.org/10.1007/s10529-006-9227-z DB - PRIME DP - Unbound Medicine ER -